-
Je něco špatně v tomto záznamu ?
Wnt/beta-catenin signaling: a promising new target for fibrosis diseases
Y. Guo, L. Xiao, L. Sun, F. Liu
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- beta-katenin genetika metabolismus MeSH
- biologické modely MeSH
- fibróza farmakoterapie metabolismus MeSH
- lidé MeSH
- mikro RNA metabolismus MeSH
- signální dráha Wnt * MeSH
- signální transdukce MeSH
- transformující růstový faktor beta genetika metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Wnt/beta-catenin signaling is involved in virtually every aspect of embryonic development and also controls homeostatic self-renewal in a number of adult tissues. Recently, emerging evidence from researches of organ fibrosis suggest that sustained Wnt/beta-catenin pathway reactivation is linked to the pathogenesis of fibrotic disorders. Here we focus on Wnt/beta-catenin-related pathogenic effects in different organs, such as lung fibrosis, liver fibrosis, skin fibrosis and renal fibrosis. Additionally, Wnt/beta-catenin signaling works in a combinatorial manner with TGF-beta signaling in the process of fibrosis, and TGF-beta signaling can induce expression of Wnt/beta-catenin superfamily members and vice versa. Moreover, network analysis, based on pathway databases, revealed that key factors in the Wnt pathway were targeted by some differentially expressed microRNAs detected in fibrosis diseases. These findings demonstrated the crosstalks between Wnt/beta-catenin pathway and TGF-beta signalings, and microRNAs, highlighting the role of Wnts in organ fibrogenesis. Most importantly, nowadays there is a variety of Wnt pathway inhibitors which give us the potential therapeutic feasibility, modulation of the Wnt pathway may, therefore, present as a suitable and promising therapeutic strategy in the future.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13033327
- 003
- CZ-PrNML
- 005
- 20131025121319.0
- 007
- ta
- 008
- 131015s2012 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932289 $2 doi
- 035 __
- $a (PubMed)22670697
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Guo, Y. $u Department of Nephrology, Second Xiangya Hospital, Central South University, Changsha, PR China
- 245 10
- $a Wnt/beta-catenin signaling: a promising new target for fibrosis diseases / $c Y. Guo, L. Xiao, L. Sun, F. Liu
- 520 9_
- $a Wnt/beta-catenin signaling is involved in virtually every aspect of embryonic development and also controls homeostatic self-renewal in a number of adult tissues. Recently, emerging evidence from researches of organ fibrosis suggest that sustained Wnt/beta-catenin pathway reactivation is linked to the pathogenesis of fibrotic disorders. Here we focus on Wnt/beta-catenin-related pathogenic effects in different organs, such as lung fibrosis, liver fibrosis, skin fibrosis and renal fibrosis. Additionally, Wnt/beta-catenin signaling works in a combinatorial manner with TGF-beta signaling in the process of fibrosis, and TGF-beta signaling can induce expression of Wnt/beta-catenin superfamily members and vice versa. Moreover, network analysis, based on pathway databases, revealed that key factors in the Wnt pathway were targeted by some differentially expressed microRNAs detected in fibrosis diseases. These findings demonstrated the crosstalks between Wnt/beta-catenin pathway and TGF-beta signalings, and microRNAs, highlighting the role of Wnts in organ fibrogenesis. Most importantly, nowadays there is a variety of Wnt pathway inhibitors which give us the potential therapeutic feasibility, modulation of the Wnt pathway may, therefore, present as a suitable and promising therapeutic strategy in the future.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a fibróza $x farmakoterapie $x metabolismus $7 D005355
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikro RNA $x metabolismus $7 D035683
- 650 _2
- $a biologické modely $7 D008954
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a transformující růstový faktor beta $x genetika $x metabolismus $7 D016212
- 650 12
- $a signální dráha Wnt $7 D060449
- 650 _2
- $a beta-katenin $x genetika $x metabolismus $7 D051176
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Xiao, L. $u Department of Nephrology, Second Xiangya Hospital, Central South University, Changsha, PR China
- 700 1_
- $a Sun, L. $u Department of Nephrology, Second Xiangya Hospital, Central South University, Changsha, PR China
- 700 1_
- $a Liu, F. $u Department of Nephrology, Second Xiangya Hospital, Central South University, Changsha, PR China
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 61, č. 4 (2012), s. 337-346
- 856 41
- $u http://www.biomed.cas.cz/physiolres/archive.htm $y domovská stránka časopisu - plný text volně přístupný = fulltext
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 3 $z 0
- 990 __
- $a 20131015 $b ABA008
- 991 __
- $a 20131023095708 $b ABA008
- 999 __
- $a ok $b bmc $g 998633 $s 831781
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 61 $c 4 $d 337-346 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK111 $a Pubmed-20131015